METHOCARBAMOL TABLE
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The Defense Logistics Agency awarded contract SPE2DP20F5852 to DMS Pharmaceutical Group Inc on August 24, 2026. This award is issued as a delivery order under the primary contract SPE2DX15D9383 for the procurement of Methocarbamol tablets, identified by National Stock Number 6505015049519. The agreement is managed by the Department of Defense and was posted via the DIBBS system. While the total contract price is specified within the award documentation, the primary objective of the order is the supply of the designated pharmaceutical line item to the federal agency.
General Info
Agency
NAICS
Place of Performance
Not specifiedSet-Aside
Documents
(2)AI Contract Breakdown
Uniform Contract FormatWhat is UCF?
Uniform Contract Format (UCF) uses AI to break down any contract into standardized sections—scope, pricing, deliverables, and evaluation criteria.
Timeline
Organization & Contact Information
Full Description
Similar Contracts
Same NAICS industry code
More opportunities from Department Of Defense → Defense Logistics Agency
Same awarding agency
Ready to Pursue This Opportunity?
Get AI-powered intelligence on this solicitation and the ones like it
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 650+ contractors already using CLEATUS
